Cogent Biosciences, Inc.

COGT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001622229

SEC filings (opens in a new tab)

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Cogent Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of COGT: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	146	3	149	+6
Shares	109.3M	75.3K	121.4M	+12.2M (+11.2%)
Value	$734.3M	$505.4K	$1.02B	+$289.7M (+39.5%)

3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Cogent Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to COGT in Q2 2024
Institution	Shares	Value	% of portfolio
Paradigm Biocapital Advisors LP	3,624,342	$30.6M	1.17%
Eventide Asset Management, LLC	1,398,992	$11.8M	0.20%
Franklin Resources Inc	1,000,116	$8.43M	0.00%
Hennion & Walsh Asset Management, Inc.	127,712	$1.08M	0.06%
Alps Advisors Inc	74,598	$628.9K	0.00%
Corebridge Financial, Inc.	49,367	$416.2K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	49,228	$415.1K	0.00%
Y-Intercept (Hong Kong) Ltd	44,859	$378.2K	0.02%
Balyasny Asset Management LLC	44,441	$374.6K	0.00%
Tudor Investment Corp Et Al	42,532	$358.5K	0.00%
Brevan Howard Capital Management LP	22,559	$190.2K	0.01%
Catalyst Funds Management Pty Ltd	17,600	$148.4K	0.04%
Schroder Investment Management Group	16,598	$139.9K	0.00%
Laurion Capital Management LP	13,612	$114.7K	0.00%
Corton Capital Inc.	12,162	$102.5K	0.05%
Ameriprise Financial Inc	12,005	$101.2K	0.00%
Colony Group, LLC	11,628	$98.0K	0.00%
Creative Planning	11,052	$93.2K	0.00%
Quest Partners LLC	10,561	$89.0K	0.01%
Advisor Group Holdings, Inc.	1,786	$15.1K	0.00%
Lindbrook Capital, LLC	376	$3.17K	0.00%
Smartleaf Asset Management LLC	273	$2.30K	0.00%
US Bancorp	137	$1.16K	0.00%
Innealta Capital, LLC	86	$725	0.00%
Rothschild Investment LLC	70	$590	0.00%
SRS Capital Advisors, Inc.	28	$237	0.00%
Federated Hermes, Inc.	1	$8	0.00%
CWM, LLC	15	$0	0.00%

Sold out (22)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of COGT in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Perceptive Advisors LLC	883,333	$5.94M
Ghost Tree Capital, LLC	450,000	$3.02M
Suvretta Capital Management, LLC	316,000	$2.12M
Renaissance Technologies LLC	299,668	$2.01M
Lighthouse Investment Partners, LLC	167,878	$1.13M
Qube Research & Technologies Ltd	123,017	$826.7K
New York Life Investment Management LLC	61,111	$410.7K
American International Group, Inc.	40,935	$275.1K
XTX Topco Ltd	32,851	$220.8K
UBS Oconnor LLC	22,442	$150.8K
Aigen Investment Management, LP	17,822	$119.8K
Squarepoint Ops LLC	16,843	$113.2K
Dark Forest Capital Management LP	16,744	$112.5K
Oxford Asset Management LLP	15,808	$106.2K
SG Americas Securities, LLC	14,750	$99.0K
Victory Capital Management Inc	11,470	$77.1K
Caption Management, LLC	9,400	$63.2K
Simplex Trading, LLC	7,303	$49.0K
Metropolitan Life Insurance Co	3,461	$23.3K
Quarry LP	1,500	$10.1K
Quadrant Capital Group LLC	689	$4.63K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	16	$107

Not filed for Q2 2024 yet (3)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COGT in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	63,289	$425.3K
Connectus Wealth, LLC	11,628	$78.1K
Cutler Group LP	386	$2.00K